US81752R1005 - Common Stock
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Seritage Growth Properties ("Seritage" or the "Company") (NYSE: SRG). Such...
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Let's take a look at the stocks that are in motion in today's session.
In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
Seritage Growth Props just reported results for the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Seritage Growth Props (NYSE:SRG) just reported results for the first quarter of...
Management decided to throw in the towel, but this company's asset value could be far more than its stock price.
Seritage Growth Props just reported results for the fourth quarter of 2023.
Seritage Growth Properties (SRG) has made a voluntary prepayment of $30M towards its $1.6M term loan facility provided by Berkshire Hathaway.
REITs should be on your watchlist this year in the face of falling interest rates. Here are some interesting options to consider.
Edward Lampert, 10% owner of Seritage Growth Properties (SRG), sold 148.1K class A common shares at $9.19 per share on Nov.
Seritage Growth Properties reports Q3 2023 operating results with a 78.5% YoY decrease in revenue and a GAAP EPS of -$0.04.
Seritage Growth Properties voluntarily prepaid $80M towards its term loan, reducing annual interest expenses by $5.6M and decreasing outstanding debt.
Novavax and Seritage Growth Properties have unusually high short interest and potential short squeeze catalysts.